This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Xuzhou Medical University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Long Ma: Innovator in Pharmaceutical Composition
Introduction
Long Ma is a notable inventor based in Xuzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in addressing morphine-induced analgesic tolerance. His innovative approach combines a short peptide with morphine to enhance therapeutic outcomes.
Latest Patents
Long Ma holds a patent for a pharmaceutical composition and method aimed at relieving or eliminating morphine-induced analgesic tolerance. The patent discloses a composition that includes a therapeutically effective amount of a short peptide and morphine as active ingredients, along with a pharmaceutically acceptable carrier. The short peptide consists of an amino acid sequence as specified in SEQ ID NO: 1 or a pharmaceutically acceptable salt thereof. The method involves administering the short peptide and morphine to a subject simultaneously or sequentially.
Career Highlights
Long Ma is affiliated with Xuzhou Medical University, where he continues to advance his research in pharmaceutical sciences. His work has garnered attention for its potential to improve pain management strategies.
Collaborations
Long Ma collaborates with esteemed colleagues, including Qiongyao Tang and Zhe Zhang, who contribute to his research endeavors.
Conclusion
Long Ma's innovative work in pharmaceutical compositions represents a significant advancement in the field of pain management. His contributions are poised to make a lasting impact on the treatment of analgesic tolerance.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile